Latest News about NVS
Recent news which mentions NVS
U.S. COVID death toll above 518,000 as Biden adds voice to outrage at Texas and Mississippi for reopening
March 04, 2021
From MarketWatch
From Benzinga
2 Best Pharma Stocks to Buy Right Now
February 23, 2021
From Motley Fool
The Week Ahead In Biotech: J&J Vaccine Adcom Meeting, Sarepta FDA Decision And Plenty Of Earnings
February 20, 2021
From Benzinga
Here's What Caused Royalty Pharma's Mixed Results in Q4
February 17, 2021
From Motley Fool
The Daily Biotech Pulse: Novartis Funding For Gene Therapy Research, Priority Review For Amgen Cancer Drug, Pfizer-BioNTech Vaccine Supply Deal
February 17, 2021
From Benzinga
2 Top Biotech Stocks to Buy in February
February 17, 2021
From Motley Fool
What's Behind Incyte's Better-Than-Expected Q4 Earnings
February 09, 2021
From Motley Fool
Forget Gamestop! This Highly Shorted Stock Is a Strong Buy Now
February 09, 2021
From Motley Fool
The Daily Biotech Pulse: Novartis COVID-19 Drug Readout, Merck And Roche Earnings, 3 IPOs
February 04, 2021
From Benzinga
Let’s stick to facts about COVID-19 vaccines: There aren’t ‘dozens’ of drug companies who can step in to produce more
February 03, 2021
From MarketWatch
2 Growth Stocks for In-the-Know Investors
February 03, 2021
From Motley Fool
The Week Ahead In Biotech: Merck, Pfizer In Earnings Mix, Plus Adamas, Mallinckrodt FDA Decisions, IPOs And More
January 30, 2021
From Benzinga
Here's Why Everybody's Talking About Aurinia Pharmaceuticals Stock
January 27, 2021
From Motley Fool
Why Novartis, Seelos Therapeutics And More Are Moving Today
January 26, 2021
From Benzinga
The Daily Biotech Pulse: Novartis Misses, J&J Beats In Big Pharma Earnings, Vaccine Developer CureVac Taps Equity Market
January 26, 2021
From Benzinga
Earnings Scheduled For January 26, 2021
January 26, 2021
From Benzinga
Piclidenoson From Can-Fite Biopharma Shows New, Promising Developments For Psoriasis Treatment
January 19, 2021
From Benzinga
Why Novartis, BioVie, Esperion And VBI Are Moving Today
January 15, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 15, 2021
January 15, 2021
From Benzinga
Invitae Nabs Bristol Myers Squibb, J&J, Novartis, and Roche for Acute Myeloid Leukemia Project
January 14, 2021
From Motley Fool
The Daily Biotech Pulse: GSK, Vir To Start COVID-19 Antibody Study, Novartis In-Licenses BeiGene's Cancer Drug, Earnings Preannouncements Continue
January 12, 2021
From Benzinga
These Were the 5 Best Diagnostics Stocks of 2020
January 09, 2021
From Motley Fool
European stocks and U.S. equity futures trade higher as investors welcome U.S. stimulus package and Brexit deal
December 28, 2020
From MarketWatch
From Benzinga
2 Ultra-High-Growth Healthcare Stocks That Are Just Getting Started
December 23, 2020
From Motley Fool
Should Investors Consider This Biotech Takeover Target?
December 21, 2020
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Market Action
MARKET NEWS
Home | Individual investors | Institutional investors | Find an advisor | Opportunities at Winslow | About | News | Contact | Mobile | Site map
Privacy | Legal notices | Copyright 2021 Winslow, Evans & Crocker, Inc.
Broker/Dealer, SEC Registered Investment Advisor, MSRB Registered Company | Member FINRA, SIPC
Accounts are carried by Pershing LLC, member FINRA, NYSE, SIPC, a wholly owned subsidiary of The Bank of New York Mellon Corporation (BNY Mellon)
Accounts carried by Raymond James & Associates, Inc., member New York Stock Exchange / SIPC
Privacy | Legal notices | Copyright 2021 Winslow, Evans & Crocker, Inc.
Broker/Dealer, SEC Registered Investment Advisor, MSRB Registered Company | Member FINRA, SIPC
Accounts are carried by Pershing LLC, member FINRA, NYSE, SIPC, a wholly owned subsidiary of The Bank of New York Mellon Corporation (BNY Mellon)
Accounts carried by Raymond James & Associates, Inc., member New York Stock Exchange / SIPC